Therapeutics. Pharmacology

Безопасность и риск фармакотерапии

No APC Verified OA Visit journal

Безопасность и риск фармакотерапии is a peer-reviewed russian-language open-access journal published by Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» in Russian Federation, operating under an open-access model since 2015. The journal covers Therapeutics. Pharmacology.

Authors publish in Безопасность и риск фармакотерапии without paying any article processing charge (APC) — making it a fully diamond/platinum open-access venue, supported entirely by its publisher or sponsor. Articles are released under the CC BY license (see other journals using this license).

Keywords

drug safety, undesirable side reactions, signals, risks of pharmacotherapy, pharmacovigilance

At a glance

Primary language
Russian
License
CC BY
Peer review
Double anonymous peer review
OA since
2015

ISSN

print
2312-7821
electronic
2619-1164

Frequently asked questions

Is Безопасность и риск фармакотерапии peer-reviewed?
Yes — Безопасность и риск фармакотерапии operates a Double anonymous peer review review process.
Does Безопасность и риск фармакотерапии charge an article processing charge (APC)?
No. Безопасность и риск фармакотерапии does not charge any APC. Publication is free for accepted authors.
What subjects does Безопасность и риск фармакотерапии publish?
Безопасность и риск фармакотерапии publishes research in Therapeutics. Pharmacology.
What languages does Безопасность и риск фармакотерапии accept?
Безопасность и риск фармакотерапии accepts manuscripts in Russian.
What is the ISSN of Безопасность и риск фармакотерапии?
ISSN: 2312-7821 (print) · 2619-1164 (electronic).
How do I submit a manuscript to Безопасность и риск фармакотерапии?
Submit through the journal's official portal: visit submission page →

Similar journals

Other open-access journals in Therapeutics. Pharmacology.

Help us grow the directory

Know an open-access journal we don't list yet?

Add it in under a minute. Each suggestion is reviewed by a human editor.

WhatsApp